SEC Filing Summary: Eyenovia, Inc. (EYEN)
Business Context and Reporting Period
This Form 8-K was filed on February 25, 2025, by Eyenovia, Inc. (Note: The request metadata referenced "Hyperion Defi, Inc.", but the filing text explicitly identifies the registrant as Eyenovia, Inc.). The report addresses the company's compliance status with The Nasdaq Stock Market LLC listing requirements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance relative to Nasdaq listing rules.
Material Changes
- Regained Compliance: As of February 20, 2025, the company's common stock bid price closed above the $1.00 per share Minimum Bid Requirement.
- Delisting Avoidance: The company successfully avoided delisting after previously triggering the "Low Priced Stocks Rule" in December 2024, which had threatened to remove the stock from the Nasdaq Capital Market.
- Reverse Stock Split: On January 31, 2025, the company effected a reverse stock split to comply with an exception granted by a Nasdaq Hearings Panel.
Outlook, Risks, and Management Commentary
Nasdaq has confirmed that the listing of the company's common stock on the Nasdaq Capital Market will continue. The primary risk previously associated with the stock price falling below $1.00 for 30 consecutive days has been resolved for the current period. No forward-looking guidance or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the current trading price of EYEN to ensure it remains above the $1.00 threshold.
- Review the January 31, 2025 Form 8-K for details on the reverse stock split ratio and its impact on share count.
- Confirm the company's ongoing compliance with other Nasdaq listing rules beyond the bid price requirement.